STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Sarcoma
Leiomyosarcoma
Dedifferentiated Liposarcoma

Interventions

COMBINATION_PRODUCT: STC-15 in combination with toripalimab
DRUG: STC-15 monotherapy

Sponsor

STORM Therapeutics LTD

Collaborators

[object Object]